Lauriad® is an innovative technology for high-performance delivery.
Lauriad®: a new cutting edge technology with the potential of improving the use and efficiency of existing API.

Lauriad®'s targeted action avoids the first-pass hepatic effect:

    • Limitation of drug interactions and adverse effects

Lauriad®’s targeted action avoids gastrointestinal enzymatic degradation

Lauriad® technology enables a targeted action at the site of infection by releasing an early, effective and prolonged concentration of an active substance:

    • Limitation of doses
    • Improving compliance
    • Improving treatment outcomes
    • ecology of drug taking